A Novel Skeleton Compound from Streptomyces canarius SN0246: Isolation, Purification, and Structural Elucidation

Area of Science:

• Microbiology
• Natural Product Chemistry
• Agricultural Science

Background:

• Streptomyces species are prolific producers of diverse secondary metabolites with potential bioactivities.
• The development of new fungicides is crucial for managing crop diseases and ensuring food security.

Purpose of the Study:

• To isolate and characterize novel compounds from Streptomyces canarius SN0246.
• To evaluate the in vitro antifungal activity of the isolated compound against the crop pathogenic fungus Rhizoctonia solani.

Main Methods:

• Isolation and purification of the compound from fermentation broth.
• Structure elucidation using nuclear magnetic resonance (NMR) spectroscopy and high-resolution mass spectrometry (HRMS).
• In vitro antifungal bioassay to determine the EC50 value against Rhizoctonia solani.

Main Results:

• A novel compound, named canakingmycin, was successfully isolated and its structure elucidated.
• Canakingmycin demonstrated significant inhibitory effects on the mycelial growth of Rhizoctonia solani.
• The EC50 value for canakingmycin against Rhizoctonia solani was determined to be 76.13 μg/mL.

Conclusions:

• Canakingmycin represents a new chemical entity with promising antifungal properties.
• This study contributes to the known structural diversity of Streptomyces secondary metabolites.
• Canakingmycin serves as a potential lead molecule for the development of novel bio-based fungicides.